Evidence map›Paper›PMID 21178763›Full record

Trial reportAnnals of surgery2011

Out-of-hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial.

Eileen M Bulger, Susanne May, Jeffery D Kerby, Scott Emerson, Ian G Stiell, Martin A Schreiber, Karen J Brasel, Samuel A Tisherman, Raul Coimbra, Sandro Rizoli and 6 more

2 registry-linked trialsAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Annals of surgery, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 106 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed, 11 pooled it
11.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00316017 phase3terminatednot on this map

Phase 3 Study of Hypertonic Resuscitation Following Traumatic Injury With Hypovolemic Shock

TypeinterventionalSponsorUniversity of WashingtonRan2006 to 2009Enrolled895ConditionsShock, TraumaticArms7.5% hypertonic saline/6% Dextran-70 (HSD), 7.5% hypertonic saline (HS), 0.9% normal saline
NCT02440373 completednot on this mapstarted 2014, after this paper: background citation

Plasma Cytochrome c as Biomarker of Traumatic Injury and Predictor of Outcome

TypeobservationalSponsorWake Forest University Health SciencesRan2014 to 2017Enrolled12ConditionsTrauma, Blunt Injury, Blunt Trauma, Accident
3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 11 syntheses or guidelines pooled it, 283 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Randomised controlled trials in pre-hospital trauma: a systematic mapping review.Scandinavian journal of trauma, resuscitation and emergency medicine · 2021
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Guideline
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 2 countries.

Eileen M BulgerDepartment of Surgery, University of Washington, Seattle, WA, USA.ebulger@u.washington.edu
Susanne May
Jeffery D Kerby
Scott Emerson
Ian G Stiell
Martin A Schreiber
Karen J Brasel
Samuel A Tisherman
Raul Coimbra
Sandro Rizoli
Joseph P Minei
J Steven Hata
George Sopko
David C Evans
David B Hoyt
ROC investigators
The University of Texas Southwestern Medical Center · USUniversity of Toronto · CAMedical College of Wisconsin · USOregon Health & Science University · USUniversity of Pittsburgh · USUniversity of California, San Diego · USUniversity of Ottawa · CAUniversity of Washington · US

Funding

Resuscitation Outcomes Consortium (ROC) Data Coordinating CenterU01HL077863 · NHLBI · UNIVERSITY OF WASHINGTON · PI MAY, SUSANNE · 2004 to 2015
$125.1M
Resuscitation Outcomes Consortium (ROC) Regional Clinical Center-PittsburghU01HL077871 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CALLAWAY, CLIFTON W. · 2004 to 2015
$4.0M
Southeastern Resucitation Research CenterU01HL077881 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KERBY, JEFFREY D, WANG, HENRY E. · 2004 to 2015
$3.9M
Resuscitation Outcomes Consortium (ROC) Regional Clinical Center-PortlandU01HL077873 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI DAYA, MOHAMUD RAMZANALI · 2004 to 2015
$3.9M
Resuscitation Outcomes Consortium Regional Clinical Center-DFW Center for ResusciU01HL077887 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI IDRIS, AHAMED H · 2004 to 2015
$3.2M
Resuscitation Outcomes Consortium (ROC) Regional Clinical Centers-MilwaukeeU01HL077866 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI AUFDERHEIDE, TOM PAUL · 2004 to 2015
$3.0M
Seattle-King County Center for Resuscitation ResearchU01HL077867 · NHLBI · UNIVERSITY OF WASHINGTON · PI KUDENCHUK, PETER JAMES · 2004 to 2015
$3.0M
The UCSD/San Diego Resuscitation Research CenterU01HL077908 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI VILKE, GARY · 2004 to 2015
$2.9M
Resuscitation Outcomes Consortium (ROC) Regional Clinical Center-OTTAWA-OPALS-BCRU01HL077885 · NHLBI · OTTAWA HOSPITAL RESEARCH INSTITUTE · PI STIELL, IAN G. · 2004 to 2015
$2.4M
Resuscitation Outcomes Consortium (ROC) Regional Clinical Center-Toronto RegionalU01HL077872 · NHLBI · ST. MICHAEL'S HOSPITAL · PI MORRISON, LAURIE · 2004 to 2015
$1.9M
The Iowa Resuscitation Network:A Rural Regional Clin CtrU01HL077865 · NHLBI · UNIVERSITY OF IOWA · PI KERBER, RICHARD E · 2004 to 2007
$1.7M
CIHRNHLBI NIH HHS 5U01 HL077863NHLBI NIH HHS HL077865NHLBI NIH HHS HL077866NHLBI NIH HHS HL077867NHLBI NIH HHS HL077872NHLBI NIH HHS HL077873NHLBI NIH HHS HL077881NHLBI NIH HHS HL077885NHLBI NIH HHS HL077887NHLBI NIH HHS HL077908NHLBI NIH HHS U01 HL077863NHLBI NIH HHS U01 HL077865NHLBI NIH HHS U01 HL077866NHLBI NIH HHS U01 HL077867NHLBI NIH HHS U01 HL077871NHLBI NIH HHS U01 HL077872NHLBI NIH HHS U01 HL077873NHLBI NIH HHS U01 HL077881NHLBI NIH HHS U01 HL077885NHLBI NIH HHS U01 HL077887NHLBI NIH HHS U01 HL077908
6 · The paper itself

Abstract

objectiveTo determine whether out-of-hospital administration of hypertonic fluids would improve survival after severe injury with hemorrhagic shock.

backgroundHypertonic fluids have potential benefit in the resuscitation of severely injured patients because of rapid restoration of tissue perfusion, with a smaller volume, and modulation of the inflammatory response, to reduce subsequent organ injury.

methodsMulticenter, randomized, blinded clinical trial, May 2006 to August 2008, 114 emergency medical services agencies in North America within the Resuscitation Outcomes Consortium. INCLUSION CRITERIA: injured patients, age ≥ 15 years with hypovolemic shock (systolic blood pressure ≤ 70 mm Hg or systolic blood pressure 71-90 mm Hg with heart rate ≥ 108 beats per minute). Initial resuscitation fluid, 250 mL of either 7.5% saline per 6% dextran 70 (hypertonic saline/dextran, HSD), 7.5% saline (hypertonic saline, HS), or 0.9% saline (normal saline, NS) administered by out-of-hospital providers. Primary outcome was 28-day survival. On the recommendation of the data and safety monitoring board, the study was stopped early (23% of proposed sample size) for futility and potential safety concern.

results: A total of 853 treated patients were enrolled, among whom 62% were with blunt trauma, 38% with penetrating. There was no difference in 28-day survival-HSD: 74.5% (0.1; 95% confidence interval [CI], -7.5 to 7.8); HS: 73.0% (-1.4; 95% CI, -8.7-6.0); and NS: 74.4%, P = 0.91. There was a higher mortality for the postrandomization subgroup of patients who did not receive blood transfusions in the first 24 hours, who received hypertonic fluids compared to NS [28-day mortality-HSD: 10% (5.2; 95% CI, 0.4-10.1); HS: 12.2% (7.4; 95% CI, 2.5-12.2); and NS: 4.8%, P < 0.01].

conclusionAmong injured patients with hypovolemic shock, initial resuscitation fluid treatment with either HS or HSD compared with NS, did not result in superior 28-day survival. However, interpretation of these findings is limited by the early stopping of the trial. CLINICAL

trial registrationClinical Trials.gov, NCT00316017.

Indexed as

Early Termination of Clinical TrialsEmergency Medical ServicesAdultBlood TransfusionCohort StudiesCombined Modality TherapyDextransDouble-Blind MethodFemaleHospital MortalityHumansHypertonic SolutionsMaleMiddle AgedSaline Solution, HypertonicShockDextransHypertonic SolutionsSaline Solution, Hypertonic

Identifiers

PMID21178763
PMCPMC3232054
OpenAlexW2164315467

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.